2 news items
Ionis, Biogen Down on Ending Development of ALS Drug
BIIB
HRTX
IONS
17 May 24
intends to advance ION582 independently as part of its wholly-owned pipeline. In fact, it also posted positive topline results from a phase I/IIa study
Merck Ends Keytruda Combo Melanoma Study Due to Futility
ANIP
LGND
MRK
14 May 24
unlikely that the study could achieve a statistically significant improvement in RFS.
Accordingly, an independent Data Monitoring Committee
- Prev
- 1
- Next